Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022
April 22, 2022 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2022 financial results...
Assertio Holdings, Inc. Partners with BlinkRx to Support Healthcare Providers and Patients Utilizing Otrexup® (methotrexate) with a Unique Patient Access Solution
March 31, 2022 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT) and BlinkRx, the leading patient access solution, today announced a collaboration to support...
Assertio Reports Fourth Quarter and Full Year 2021 Financial Results
March 09, 2022 08:30 ET
|
Assertio Holdings, Inc.
$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4 Million Full Year Net Product Sales $17.8 Million Fourth Quarter Non-GAAP Adjusted EBITDA, a 118%...
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results Before the Opening of Markets on Wednesday, March 9, 2022
March 02, 2022 09:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., March 02, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2021...
Assertio Holdings, Inc. to Participate in the H.C. Wainwright BioConnect Virtual Conference
January 10, 2022 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced that the Company’s Chief Executive Officer, Dan Peisert, and...
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.
December 15, 2021 17:35 ET
|
Assertio Holdings, Inc.
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0 Million Upfront and an Additional $26.0 Million in Deferred Payments Raises Full Year Net Product...
Assertio Holdings, Inc. Announces Preliminary Court Approval of Shareholder Derivative Settlement
November 12, 2021 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that on October 28, 2021, the Superior Court of the State of...
Assertio Reports Third Quarter 2021 Financial Results
November 04, 2021 16:01 ET
|
Assertio Holdings, Inc.
Raises Full Year Net Product Sales and Non-GAAP Adjusted EBITDA Guidance Net Product Sales of $26.0 Million Quarterly Net Cash Flows from Operating Activities of $4.7 Million, Representing Second...
Assertio Holdings, Inc. to Report Third Quarter 2021 Financial Results After the Close of Markets on Thursday, November 4, 2021
October 26, 2021 09:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release third quarter 2021 financial results on...
Assertio Holdings, Inc. to Participate in Upcoming Investor Events
October 04, 2021 09:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced that the Company’s Chief Executive Officer, Dan Peisert, and...